Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.9 USD | +1.05% |
|
+7.38% | +81.64% |
06-24 | Needham Initiates Praxis Precision Medicines at Buy With $145 Price Target | MT |
06-24 | Praxis Precision Medicines, Inc.(NasdaqGS:PRAX) added to S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.64% | 692M | |
+22.52% | 46.93B | |
+36.98% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+32.23% | 12.53B | |
-6.56% | 11.36B | |
-13.11% | 10.65B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Guggenheim Initiates Praxis Precision Medicines With Buy Rating, $155 Price Target